News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,260 Results
Type
Article (49163)
Company Profile (311)
Press Release (672786)
Section
Business (212018)
Career Advice (2080)
Deals (36480)
Drug Delivery (93)
Drug Development (83366)
Employer Resources (169)
FDA (16892)
Job Trends (15664)
News (358659)
Policy (34596)
Tag
Academia (2759)
Alliances (51246)
Alzheimer's disease (1274)
Approvals (16810)
Artificial intelligence (138)
Bankruptcy (364)
Best Places to Work (11977)
Biotechnology (216)
Breast cancer (122)
Cancer (1061)
Cardiovascular disease (91)
Career advice (1745)
Cell therapy (220)
Clinical research (65992)
Collaboration (370)
Compensation (189)
COVID-19 (2653)
C-suite (91)
Data (1030)
Diabetes (155)
Diagnostics (6337)
Earnings (86840)
Employer resources (147)
Events (114227)
Executive appointments (284)
FDA (17398)
Funding (330)
Gene therapy (171)
GLP-1 (619)
Government (4591)
Healthcare (19744)
Infectious disease (2738)
Inflammatory bowel disease (108)
Interviews (316)
IPO (16646)
Job creations (4038)
Job search strategy (1496)
Layoffs (429)
Legal (8405)
Lung cancer (167)
Manufacturing (170)
Medical device (14161)
Medtech (14166)
Mergers & acquisitions (19876)
Metabolic disorders (418)
Neuroscience (1544)
NextGen Class of 2024 (6900)
Non-profit (4723)
Northern California (1408)
Obesity (246)
Opinion (192)
Patents (99)
People (59030)
Phase I (20472)
Phase II (29000)
Phase III (21688)
Pipeline (409)
Postmarket research (2731)
Preclinical (8749)
Radiopharmaceuticals (244)
Rare diseases (206)
Real estate (6286)
Regulatory (22890)
Research institute (2471)
Resumes & cover letters (359)
Southern California (1254)
Startups (3817)
United States (13167)
Vaccines (585)
Weight loss (188)
Date
Today (198)
Last 7 days (992)
Last 30 days (3699)
Last 365 days (36343)
2024 (32683)
2023 (41149)
2022 (52384)
2021 (57104)
2020 (55921)
2019 (48803)
2018 (36947)
2017 (33750)
2016 (33575)
2015 (39617)
2014 (33328)
2013 (28568)
2012 (30857)
2011 (31558)
2010 (29926)
Location
Africa (790)
Arizona (198)
Asia (40222)
Australia (6626)
California (3175)
Canada (1243)
China (239)
Colorado (146)
Connecticut (149)
Europe (87002)
Florida (436)
Georgia (118)
Illinois (360)
Indiana (194)
Kansas (99)
Maryland (582)
Massachusetts (2547)
Michigan (154)
Minnesota (275)
New Jersey (922)
New York (925)
North Carolina (741)
Northern California (1408)
Ohio (134)
Pennsylvania (809)
South America (1182)
Southern California (1254)
Texas (438)
Utah (89)
Washington State (356)
722,260 Results for "fuse medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results
On August 14, 2023, Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its quarterly report on Form 10-Q for the quarter ended June 30, 2023 with the Securities and Exchange Commission (“SEC”).
August 15, 2023
·
10 min read
Lone Star Bio
Fuse Medical, Inc. Fiscal Year 2022 Financial Results
Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its annual report on Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission (“SEC”) on April 14, 2023.
April 18, 2023
·
11 min read
Business
Fuse Oncology Announces Strategic Collaboration with Radiation Oncology Leader
Fuse Oncology (Fuse), a leading innovator in cutting-edge radiation oncology solutions, announced today a strategic collaboration with the University of Michigan, a recognized leader in radiation oncology.
December 14, 2023
·
2 min read
Bio NC
Fuse Oncology Unveils FuseDocs: Newest RadOnc Solution for Streamlining Clinical Documentation for Radiation Oncologists
Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their latest pioneering product, FuseDocs, today.
September 29, 2023
·
3 min read
Business
Fuse Medical, Inc. Announces Third Quarter 2022 Financial Results
Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) announced for its third quarter ended September 30, 2022 and that it has filed its quarterly report on Form 10-Q for the quarter ended September 30, 2022 with the Securities and Exchange Commission (“SEC”) on November 14, 2022.
November 15, 2022
·
11 min read
Bio NC
Global Leader Advancing Cancer Treatment, Dr. Christel Smith, Joins Fuse Oncology as Chief Technology Officer
Fuse Oncology, a trailblazing leader in radiation oncology software solutions, is pleased to announce the appointment of Dr. Christel Smith as its new Chief Technology Officer.
November 20, 2023
·
3 min read
Biotech Bay
Providence Medical Technology Announces Completion of Enrollment in the FUSE Clinical Study for High-Risk Cervical Fusion Patients
Providence Medical Technology, Inc. (PMT) today announced the close of enrollment in its FUSE Study — a prospective, multicenter, randomized, Investigational Device Exemption (IDE) clinical study evaluating the safety and effectiveness of its Posterior Cervical Stabilization System (PCSS) in 3-level cervical fusion patients.
May 11, 2023
·
5 min read
Business
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors
Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.
July 1, 2024
·
2 min read
Press Releases
Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference
November 12, 2024
·
1 min read
Press Releases
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024
November 11, 2024
·
1 min read
1 of 72,226
Next
